Colorectal cancer screening

Colorectal cancer that is caught in the early stages has a 5-year survival rate of over 90%.1 Yet, only 39% of cases2 are diagnosed in early stages due to low screening rates. When this disease spreads to distant organs, the 5-year survival rate drops to 11%.3

colorectal cancer

Screening has never been easier

InSure® ONE is a convenient, at-home fecal immunochemical test (FIT) that helps screen for colorectal cancer.

FIT testing is supported by medical guidelines for early detection of colorectal cancer3-5 and studies show that the convenience of InSure ONE testing helps more people actually get the screening they need. InSure ONE offers your patients easy, stress-free collection—in the privacy of their own home with no dietary or medicinal restrictions.

Accurate colorectal screening

InSure ONE qualitatively detects human hemoglobin from blood in fecal samples,5 which may be an indication of lower gastrointestinal bleeding associated with disorders such as diverticulitis, ulcerative colitis, polyps, colorectal cancers, or large adenomas that bleed.

The InSure® ONE kit

  • Patient instructions for use
  • A test card
  • 2 long-handled brushes
  • 2 waste bags

InSure ONE comes in a patient-friendly kit that contains everything necessary to collect a water-based sample and package it for shipping in an enclosed self-mailing envelope.

InSureOne One Day Fecal Immunochemical Test

Please contact your Quest Diagnostics sales representative for instructions in additional languages.

Patient-friendly collection

The convenient water-based collection method uses unique, patented brush sampling that doesn’t require any stool collection or handling. There are no dietary or medicinal restrictions. Patients collect 2 water-based samples from a single bowel movement. This patient-friendly approach to testing is associated with up to 66% greater patient compliance.6

Every kit returned could save a life by early detection

Our InSure® ONE integrated reminder program helps encourage test compliance by sending reminder messages to patients to complete and return their collection kit. Electronic orders for InSure ONE placed in Quanum® Lab Services Manager or your EMR interface are eligible to receive reminders.

Who should be screened with InSure ONE?

Distribute kits to average-risk patients aged 45+ during annual wellness visits.

Who should be screened with InSure ONE?

Distribute kits to average-risk patients aged 45+ during annual wellness visits.

Get started with InSure® ONE in just 2 easy steps

1

Order InSure ONE kits using Quanum Lab
Services Manager using test code 11290

If you don’t have a Quanum account, create one in less than 5 minutes by clicking here. If you would prefer to order kits over the phone, please call 1.866.MYQUEST (1.866.697.8378) and state “supplies” upon connection for assistance.

Quest will ship the kits to your practice at no cost, based on usage and test completion.

If you don’t have a Quanum account, create one in less than 5 minutes by clicking here. If you would prefer to order kits over the phone, please call 1.866.MYQUEST (1.866.697.8378) and state “supplies” upon connection for assistance.

Quest will ship the kits to your practice at no cost, based on usage and test completion.

2

Print a copy of the requisition

Print a copy of the requisition and place in the postage-paid reply envelope found inside the kit before the patient leaves the office.

Print a copy of the requisition and place in the postage-paid reply envelope found inside the kit before the patient leaves the office.

TEST NAME
TEST CODE

Fecal Globin by Immunochemistry (InSure®)

Test Code: 11290

Test codes may vary by location. Please contact your local laboratory for more information.

​References:

  1. National Cancer Institute. Cancer stat facts: colorectal cancer. Accessed July 31, 2020. https://seer.cancer.gov/statfacts/html/colorect.html
  2. American Cancer Society. Colorectal cancer facts & figures 2017-2019. Published 2017. Accessed July 31, 2020. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2017-2019.pdf
  3. InSure® ONE™. K170548 – Instructions for use. Quest Diagnostics; 2017.
  4. InSure® FIT. F002457 Fecal immunochemical test immunoassay for human hemoglobin in stool. Product instructions. Enterix; 2011.
  5. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315(23):2564-2575. doi:10.1001/jama.2016.5989
  6. Cole SR, Young GP, Esterman A, et al. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen. 2003;10(3):117-122. doi:10.1177/096914130301000304